iRadimed Corporation
IRADIMED Corp designs and sells MRI-compatible medical devices used inside scanner rooms, centered on infusion pumps, patient vital signs monitoring systems, and related disposables and service. The company serves hospitals and acute care facilities that need equipment that can operate safely in the magnetic environment of MRI suites.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueScanner-room infusion pumps and associated tubing sets used to deliver medication during MRI procedures.
Vital signs monitoring systems designed to function safely in MRI environments.
Single-use tubing and related consumables sold with installed devices and recurring usage.
Extended maintenance agreements, service work, and other support tied to installed equipment.
Customers
IRADIMED sells primarily to hospitals and acute care facilities with MRI equipment on site, where clinical staff need infusion and monitoring tools that are safe in the scanner room. In the U.S., the company sells largely to end users, while internationally it relies more on distributors, which affects pricing, support, and customer access.
Buy infusion pumps, monitors, and disposables for safe use during MRI procedures and to improve workflow.
Purchase MRI-compatible devices for critical-care imaging environments where patient monitoring is essential.
Buy products for resale outside the U.S., extending market reach where direct selling is less practical.
Purchase disposables, service, and maintenance tied to existing IRADIMED equipment.
Strategy
IRADIMED is focused on growing its installed base in MRI-compatible devices while expanding recurring revenue from disposables, service, and maintenance. The company is also investing in capacity and product development, including a new facility and in-house manufacturing capability for certain components, to support growth and reduce supply dependence.
Recurring disposables and service improve revenue visibility and leverage the installed base.
The new facility is intended to accommodate growth and support operations at higher scale.
Single-sourced components create continuity risk, so internalizing key parts can improve resilience.
The 3880 monitor competes against established brands, so adoption depends on workflow and differentiation.
Geography
The business is heavily U.S.-centric, with 84% of 2025 revenue generated in the United States and 16% from international markets. International sales are supported through distributors, while the company manufactures and stores products at a single facility in Florida, creating both operational focus and concentration risk.
Risks
IRADIMED faces concentration risk from a limited product set, a single manufacturing site, and reliance on key suppliers for specialized components. It also operates in a regulated, competitive medical-device market where FDA approvals, trade restrictions, distributor execution, and long sales cycles can delay growth or pressure margins.
- Single-site manufacturing and storageImpact: HighLikelihood: Medium
Manufacturing and inventory are concentrated in one Florida facility, increasing disruption risk from operational events.
Exposure: Production continuity
- Supply-chain dependenceImpact: HighLikelihood: Medium
Critical raw materials and parts are sourced from single suppliers, including Chinese and Taiwanese manufacturers.
Exposure: Components and subassemblies
- Product concentrationImpact: HighLikelihood: Low
A large share of revenue comes from a small number of MRI-compatible devices, so demand shifts can materially affect results.
Exposure: Devices and related disposables
- Regulatory approval riskImpact: MediumLikelihood: Medium
Medical-device commercialization depends on FDA clearances and ongoing compliance, which can delay launches or require redesigns.
Exposure: New products and modifications
- Competitive pressureImpact: MediumLikelihood: Medium
Larger rivals have broader product lines, deeper resources, and established customer relationships.
Exposure: MRI-compatible monitoring and infusion systems
- International distributor dependenceImpact: MediumLikelihood: Medium
Non-U.S. sales rely on third parties, which can weaken pricing control and execution quality.
Exposure: International revenue
Accounting
Judgemental itemsDifferent timing applies to devices, disposables, maintenance amortization, and services, affecting quarterly revenue mix.
Impact: Can shift revenue between periods and affect gross margin trends
Domestic sales are generally made on open credit terms, requiring estimates for collectability.
Impact: Affects operating income and receivables valuation
Specialized components and finished goods can become obsolete or require write-downs if demand changes.
Impact: Can materially affect cost of revenue and gross profit
The new facility and related equipment increase capitalized assets and future depreciation expense.
Impact: Affects operating expense run-rate and asset carrying values
Tax expense is influenced by state taxes, R&D credits, and changing tax law, including recent U.S. tax changes.
Impact: Can move effective tax rate and net income
Third-quarter bookings are historically lower due to summer seasonality, affecting comparability across quarters.
Impact: Can create uneven revenue and order trends
Similar listed companies
Publicly listed companies with a comparable business focus.
IR-Med, Inc.
Electromedical & Electrotherapeutic Apparatus
IRIDEX Corporation
IRIX · Electromedical & Electrotherapeutic Apparatus
IRIDEX Corp is an ophthalmic medical technology company that develops and commercializes laser-based systems and related therapies for sight-threatening eye diseases.
ICU Medical, Inc
ICUI · Surgical & Medical Instruments & Apparatus
ICU Medical develops, manufactures, and sells medical devices and software used in infusion therapy, vascular access, and critical care settings.
Marimed Inc.
MRMD · Medicinal Chemicals & Botanical Products
Merit Medical Systems, Inc
MMSI · Surgical & Medical Instruments & Apparatus
Merit Medical Systems designs, manufactures, and markets proprietary medical devices used in interventional, diagnostic, and therapeutic procedures.
CONMED Corp
CNMD · Electromedical & Electrotherapeutic Apparatus
CONMED Corp is a U.S.-based medical technology company focused on devices and equipment used in surgical procedures.
Last updated: 24/09/2026